Skip to main content

MoneyWorks4Me

Kappac Pharma informs about quarterly statement on investor complaints

08 Apr 2016 Evaluate

Kappac Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1888.00
Dr. Reddys Labs. 1383.25
Cipla 1410.00
Lupin 2022.50
Zydus Lifesciences 1205.25
View more..